前動(dòng)力蛋白2(PK2)活性蛋白
Active Prokineticin 2 (PK2)
PK-2; Bv8; MIT1; KAL4; Protein Bv8 Homolog
- 編號(hào)APA115Hu02
- 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)10.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1598 ¥ 3996¥ 7992¥ 23976¥ 59940
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)

Figure. Cell proliferation of HCT116 cells after stimulated with PK2.
Prokineticin 2 (PK2) is a memeber of prokineticin family. Prokineticin is a secreted protein that potently contracts gastrointestinal smooth muscle. They are thought to be involved in several important physiological processes like neurogenesis, tissue development, angiogenesis, and nociception. Other important physiological roles the Bv8/Prokineticins (PKs) are involved in may include cancer, reproduction, and regulating physiological functions that influence circadian rhythms like hormone secretion, ingestive behaviors, and the sleep/wake cycle. To test the effect of PK2 on cell proliferation, HCT116 colon cancer cells were seeded into triplicate wells of 96-well plates at a density of 5,000 cells/well and allowed to attach, replaced with serum-free overnight, then the medium was replaced with 2% serum standard DMEM containing various concentrations of recombinant human PK2. After incubated for 96h,?cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10μL of CCK-8 solution was added to each well of the plate, then the absorbance at 450nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37℃. Proliferation of HCT116 cells after incubation with PK2 for 96h observed by inverted microscope was shown in Figure 1. Cell viability was assessed by CCK-8 (Cell Counting Kit-8) assay after incubation with recombinant PK2 for 96h. The result was shown in Figure 2. It was obviously that PK2 significantly increased cell viability of HCT116 cells.
(A) HCT116 cells cultured in DMEM, stimulated with 100ng/mL PK2 for 96h;
(B) Unstimulated HCT116 cells cultured in DMEM for 96h.

Figure. Cell proliferation of HCT116 cells after stimulated with PK2.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA115Hu01 | 前動(dòng)力蛋白2(PK2)活性蛋白 | Cell?culture;?Activity?Assays. |
APA115Hu02 | 前動(dòng)力蛋白2(PK2)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA115Hu01 | 前動(dòng)力蛋白2(PK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA115Hu02 | 前動(dòng)力蛋白2(PK2)多克隆抗體 | WB; IHC; ICC; IP. |
PAA115Hu01 | 前動(dòng)力蛋白2(PK2)多克隆抗體 | WB; IHC; ICC; IP. |
MAA115Hu22 | 前動(dòng)力蛋白2(PK2)單克隆抗體 | WB; IHC; ICC; IP. |
CEA115Hu | 前動(dòng)力蛋白2(PK2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA115Hu | 前動(dòng)力蛋白2(PK2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
MOLECULAR NEUROBIOLOGY | Roles of Prokineticin 2 in Subarachnoid Hemorrhage-Induced Early Brain Injury via Regulation of Phenotype Polarization in Astrocytes[Pubmed: 32572760] |
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared to osteoarthritis[] |